PES is frequently engaged to provide support for biomarker identification and genomics for clinical trials.


Assist in the application of surrogate biological endpoints (i.e. biomarkers) to validate an agent’s mechanism of action (MOA) and relevance to clinical endpoints; sample collection training, biobanking, and assay performance


Provide proprietary analytic applications for genomic, epigenomic and demographic inputs to establish and/or expand MOA claims (all-new IP discovered belongs to client) and differentiate responder/non-responder populations

Start Optimizing Your Clinical Trials Today!